Chem. Biodiversity 2016, 13, 602 – 612
611
obtained by methylation of (3R)- and (3R,S)-6, respec- derivatization.
tively, were used as reference compounds.
1,2-Isopropyliden-3-(3-trimethylsiloxy-
(=(2,2-dimethyl-1,3-dioxolan-4-yl)
myristoyl)glycerol
methyl 3-[(trimethylsilyl)oxy]tetradecanoate; TMSi-8).
GC/MS (70 eV) at tR 42.6 min: m/z 415 (10, [MꢀCH3]+)*,
Synthesis of the Reference Compound rac-1-Acetyl-3-
(3-hydroxymyristoyl)glycerol (= rac-Euphrasianin A; rac-
3-(Acetyloxy)-2-hydroxypropyl
anoate; rac-1). rac-1,2-Isopropyliden-3-(3-hydroxymyri-
3-hydroxytetradec- 357 (2, [MꢀTMSi]+), 275 (7), 257 (26), 217 (20), 143 (9),
115 (100), 101 (19), 73 (28); *molecular ion not observed.
stoyl)glycerol
(= rac-(2,2-Dimethyl-1,3-dioxolan-4-yl)
rac-1-(3-Hydroxymyristoyl)glycerol
(= rac-2,3-Dihy-
methyl 3-Hydroxytetradecanoate; rac-8). A mixture of (3R, droxypropyl 3-Hydroxytetradecanoate; rac-9). A quantity
S)-6 (1.00 g, 4.10 mmol), rac-1,2-isopropyliden glycerol (7,
0.65 g, 4.92 mmol) and 4-(dimethylamino)pyridine
of 1N HCl (4.35 ml) was added to a soln. of 8 (0.83 g,
2.32 mmol) in MeOH (22 ml), and the mixture was stirred
under N2 (5 h). Afterwards, the reaction was quenched by
adding satd. NaHCO3 solution (45 ml) and the aq. phase
was extracted with Et2O (3 9 80 ml). The combined
organic extracts were dried (Na2SO4), and the solvent was
removed in vacuo to yield the crude product (0.91 g).
Purification by VLC (conditions see above) gave pure 9.
(DMAP, 0.50 g, 4.10 mmol) in dried CHCl3 (20.5 ml) was
cooled in an ice/NaCl bath, while a solution of N,N0-dicy-
clohexylcarbodiimide (DCC, 0.84 g, 4.00 mmol) in 10.5 ml
CHCl3 was added under stirring. Then the mixture was stir-
red for 21 h at room temperature, and afterwards the sol-
vent was removed by vacuum rotoevaporation. The target
product 8 was isolated from the crude residue, thus Wax-like crystals; yield: 0.65 g (89% of the theory). GC/
obtained, by VLC (110.0 g TLC grade silica gel 60 G, pre-
conditioned with n-hexane). Elution of 8 was performed
with an n-hexane/AcOEt linear gradient (100:0 – 50:50, v/
v), and the corresponding compound was monitored by
MS purity (70 eV): 99% (tR 43.9 min, diastereomers were
not separated by GC) m/z 300 (0.1, [MꢀH2O]+)*, 287 (1,
[MꢀCH2OH]+), 269 (2, [MꢀCH2OHꢀH2O]+), 227 (6),
209 (7), 163 (7, [C6H11O5]+), 145 (100, [C6H9O4]+), 134
GC/MS. Two fractions, containing 8 were evaporated to (14, [C5H10O4]+), 116 (6), 97 (10), 83 (10), 75 (23), 71
dryness in vacuo; total yield: 1.24 g, 84.5% of the theory;
wax-like compound. GC/MS purity (70 eV): 98 and 93%,
(27), 57 (38); *molecular ion not observed. 1H-NMR
(CDCl3, 500 MHz): 4.23 (1 H, dd, J = 11.5, 4.3, Ha–C(3));
respectively (tR 42.8 min, diastereomers were not separated 4.22 (1 H, dd, J = 11.5, 6.5, Ha–C(30)); 4.17 (1 H, dd,
by GC) m/z 343 (24, [MꢀCH3]+)*, 325 (6,
J = 11.5, 4.2, Hb–C(30)); 4.15 (1 H, dd, J = 11.5, 6.4, Hb–C
[MꢀCH3ꢀH2O]+), 243 (4), 203 (28, [C9H15O5]+), 183 (3)); 4.06 – 4.00 (2 H, m, H–C(6, 60)); 3.95 – 3.91 (2 H, m,
(5), 159 (56, [C7H11O4]+), 145 (100, [C7H13O3]+), 116 (42), H–C(2, 20)); 3.68 (1 H, dd, J = 11.6, 3.9, Ha–C(1)); 3.67 (1
101 (51), 83 (7), 71 (21), 57 (42); *molecular ion not H, dd, J = 11.6, 3.9, Ha–C(10)); 3.59 (1 H, dd, J = 11.6,
1
observed. H-NMR (CDCl3, 500 MHz): 4.36 – 4.31 (2 H,
6.0, Hb–C(1)); 3.58 (1 H, dd, J = 11.6, 6.0, Hb–C(10)); 2.54
m, H–C(2, 20)); 4.22 (1 H, dd, J = 11.5, 4.5, Ha–C(3)); (2 H, dd, dd, J = 15.4, 3.0, 15.5, 3.0, Ha–C(5, 50)); 2.43 (2
4.18 – 4.17 (2 H, m, Ha,b–C(30)); 4.13 (1 H, dd, J = 11.5, H, dd, dd, J = 15.6, 9.6, 15.6, 9.6, Hb–C(5, 50)); 1.55 – 1.50
6.0, Hb–C(3)); 4.08 (2 H, dd, J = 8.5, 6.5, Ha–C(1, 10));
(2 H, m, H–C(7)); 1.48 – 1.39 (4 H, m overlapped, H–C
4.04 – 3.98 (2 H, m, H–C(6, 60)); 3.75 (2 H, dd, dd, J = 8.6, (70, 8)); 1.31 – 1.27 (4 H, m overlapped, H–C(80,16)); 1.26
5.8, 8.6, 5.8, Hb–C(1, 10)); 2.56 (1 H, dd, J = 16.3, 5.6, Ha–C (30 H, br. s, H–C(9,90 – 15, 150, 16)); 0.88 (6 H, t,
(5)), 2.55 (1 H, dd, J = 16.3, 5.6, Ha–(50)); 2.45 (1 H, dd, J = 7.0 Hz, H-–C(17, 170)). 13C-NMR (CDCl3, 125 MHz):
J = 16.3, 9.1, Hb–C(5)), 2.44 (1 H, dd, J = 16.3, 9.2, Hb–C 172.82 (C(4, 40)); 69.99, 69.97 (C(2, 20)); 68.47, 68.45 (C(6,
(50)); 1.55 – 1.50 (2 H, m, H–C(7)); 1.44 – 1.43 (6 H, m, H– 60)); 65.40, 65.39 (C(3, 30)); 63.26, 63.25 (C(1, 10)); 41.94,
C(20, 200)); 1.43 – 1.41 (4 H, m overlapped, H–C(70, 8)); 41.91 (C(5, 50)); 36.88, 36.87 (C(7, 70)); 31.88 (C(15, 150));
1.37 – 1.36 (6 H, m, H–C(19, 190)); 1.31 – 1.27 (4 H, m 29.65, 29.62, 29.60, 29.58, 29.52, 29.32 (C(9, 90-14, 140));
overlapped, H–C(80, 16)); 1.26 (30 H, br. s, H–C(9,90 – 15, 25.54 (C(8, 80)); 22.65 (C(16, 160)); 14.08 (C(17, 170)), 11 sig-
150, 160)); 0.88 (6 H, t, J = 7.0, H–C(17, 170)). 13C-NMR nals overlapped. Primed numbers refer to the other
(CDCl3, 125 MHz): 172.68, 172.63 (C(4, 40)); 109.92, 109.89 diastereoisomer. APCI+-MS m/z 336* [M+NH4]+, 319
(C(18, 180)); 73.47, 73.42 (C(2, 20)); 68.02, 67.92 (C(6, 60)); [M+H]+, 283 [M+HꢀH2O]+ (MS1); 301* [M+HꢀH2O]+
66.15, 66.12 (C(1, 10)); 64.86, 64.77 (C(3, 30)); 41.42, 41.37
(MS2); 117*[C5H9O3]+ (MS3); 57 (MS4). APCIꢀ-MS m/z
(C(5, 50)); 36.54, 36.51 (C(7, 70)); 31.88 (C(15, 150)); 29.61, 350* [M+MeOH]ꢀ (MS1); 317 [MꢀH]+, 299 [M–HꢀH2O]+,
29.59, 29.54, 29.53, 29.48, 29.30 (C(9, 90)–C(14, 140)); 26.63
243 [fatty acid ꢀ H]+, 225 [fatty acidꢀHꢀH2O]+, 197 [fatty
(C(20, 200)); 25.45, 25.44 (C(8, 80)); 25.25, 25.22 (C(19, 190)); acidꢀ2HꢀCOOH]+, 133 (MS2); *fragment ions. HR-MS-
22.65 (C(16, 160)); 14.07 (C(17, 170)), 10 signals overlapped. ESI+ m/z 341.2289 [M+Na]+ (calcd. for C17H34O5Na,
Primed numbers refer to the other diastereoisomer.
APCI+-MS m/z 376 [M+NH4]+, 359* [M+H]+ (MS1); 301*
[M+HꢀOC(CH3)2]+ (MS2); 283, 227, 209, 191, 117*
[C5H9O3]+ (MS3); 57 (MS4). APCIꢀ-MS m/z 390*
341.2298). Further characterization was performed by
TMSi-derivatisation. 1,2-Bis(trimethylsilyl)-3-(3-trimethyl-
siloxymyristoyl)glycerol (=2,3-bis[(trimethylsilyl)oxy]pro-
pyl 3-[(trimethylsilyl)oxy]tetradecanoate; TMSi-9). GC/MS
[M+MeOH]ꢀ (MS1); 339* [M–HꢀH2O]ꢀ (MS2); 281, 251, (70 eV) at tR 44.2 min: m/z 519 (1, [MꢀCH3]+)*, 431 (13,
207* (MS3); 189, 80 (MS4); *fragment ions. HR-MS-ESI+ [MꢀCH3ꢀTMSi]+), 379 (5), 373 (9), 309 (5), 257 (32), 219
m/z 381.2601 [M+Na]+ (calcd. for C20H38NaO5, 381.2617). (11), 147 (19), 143 (26), 129 (16), 116 (8), 103 (40), 73 (100);
Further characterization was performed by TMSi-
*molecular ion not observed.
€
© 2016 Verlag Helvetica Chimica Acta AG, Zurich